RESPONDER – diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial

Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 18; no. 1; pp. 851 - 7
Main Authors Heil, Joerg, Sinn, Peter, Richter, Hannah, Pfob, André, Schaefgen, Benedikt, Hennigs, André, Riedel, Fabian, Thomas, Bettina, Thill, Marc, Hahn, Markus, Blohmer, Jens-Uwe, Kuemmel, Sherko, Karsten, Maria Margarete, Reinisch, Mattea, Hackmann, John, Reimer, Toralf, Rauch, Geraldine, Golatta, Michael
Format Journal Article
LanguageEnglish
Published London BioMed Central 25.08.2018
BioMed Central Ltd
BMC
Subjects
Accuracy
Adjuvant chemotherapy
Biomedical and Life Sciences
Biomedicine
Biopsy
Breast cancer
Breast surgery
cancer imaging
Cancer Research
Cancer therapies
Care and treatment
Chemotherapy
Clinical trials
Diagnosis
Dissection
Health Promotion and Disease Prevention
interventional therapeutics
Mammography
Medicine/Public Health
Methods
Neoadjuvant chemotherapy
Oncology
Patient outcomes
Patients
Sampling error
Study Protocol
Surgery
Surgical Oncology
Treatment response evaluation
Ultrasonic imaging
Ultrasound
Vacuum
Vacuum-assisted biopsy
United Kingdom > UK
Germany
Neoadjuvant chemotherapy
Vacuum-assisted biopsy
Breast cancer
Treatment response evaluation
Online AccessGet full text
ISSN1471-2407
1471-2407
DOI10.1186/s12885-018-4760-4

Cover

Abstract Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery. Methods This study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%. Discussion As a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery. During the study we anticipate possible problems in patient recruitment as the VAB intervention does not provide participating patients with any personal benefit. Hence, a proficient informed consent discussion with the patient and a detailed explanation of the study aim will be crucial for patient recruitment. Another critical issue is the histopathological VAB evaluation of a non-tumorous specimen as this may have been taken either from the former tumor region (bpCR) or outside of the (former) tumor region (non-representative VAB, sampling error). Trial registration The trial has been registered at clinicaltrials.gov with the identifier NCT02948764 on October 28, 2016 and at the German Clinical Trials Register ( DRKS00011761 ) on February 20, 2017. The date of enrolment of the first participant to the trial was on March 8, 2017.
AbstractList Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery. This study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%. As a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery.
Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery. Methods This study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%. Discussion As a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery. During the study we anticipate possible problems in patient recruitment as the VAB intervention does not provide participating patients with any personal benefit. Hence, a proficient informed consent discussion with the patient and a detailed explanation of the study aim will be crucial for patient recruitment. Another critical issue is the histopathological VAB evaluation of a non-tumorous specimen as this may have been taken either from the former tumor region (bpCR) or outside of the (former) tumor region (non-representative VAB, sampling error). Trial registration The trial has been registered at clinicaltrials.gov with the identifier NCT02948764 on October 28, 2016 and at the German Clinical Trials Register ( DRKS00011761 ) on February 20, 2017. The date of enrolment of the first participant to the trial was on March 8, 2017.
Abstract Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery. Methods This study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%. Discussion As a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery. During the study we anticipate possible problems in patient recruitment as the VAB intervention does not provide participating patients with any personal benefit. Hence, a proficient informed consent discussion with the patient and a detailed explanation of the study aim will be crucial for patient recruitment. Another critical issue is the histopathological VAB evaluation of a non-tumorous specimen as this may have been taken either from the former tumor region (bpCR) or outside of the (former) tumor region (non-representative VAB, sampling error). Trial registration The trial has been registered at clinicaltrials.gov with the identifier NCT02948764 on October 28, 2016 and at the German Clinical Trials Register (DRKS00011761) on February 20, 2017. The date of enrolment of the first participant to the trial was on March 8, 2017.
Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery. Methods This study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%. Discussion As a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery. During the study we anticipate possible problems in patient recruitment as the VAB intervention does not provide participating patients with any personal benefit. Hence, a proficient informed consent discussion with the patient and a detailed explanation of the study aim will be crucial for patient recruitment. Another critical issue is the histopathological VAB evaluation of a non-tumorous specimen as this may have been taken either from the former tumor region (bpCR) or outside of the (former) tumor region (non-representative VAB, sampling error). Trial registration The trial has been registered at clinicaltrials.gov with the identifier NCT02948764 on October 28, 2016 and at the German Clinical Trials Register (DRKS00011761) on February 20, 2017. The date of enrolment of the first participant to the trial was on March 8, 2017.
Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery. This study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%. As a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery. During the study we anticipate possible problems in patient recruitment as the VAB intervention does not provide participating patients with any personal benefit. Hence, a proficient informed consent discussion with the patient and a detailed explanation of the study aim will be crucial for patient recruitment. Another critical issue is the histopathological VAB evaluation of a non-tumorous specimen as this may have been taken either from the former tumor region (bpCR) or outside of the (former) tumor region (non-representative VAB, sampling error). The trial has been registered at clinicaltrials.gov with the identifier NCT02948764 on October 28, 2016 and at the German Clinical Trials Register ( DRKS00011761 ) on February 20, 2017. The date of enrolment of the first participant to the trial was on March 8, 2017.
Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery. Methods This study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%. Discussion As a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery. During the study we anticipate possible problems in patient recruitment as the VAB intervention does not provide participating patients with any personal benefit. Hence, a proficient informed consent discussion with the patient and a detailed explanation of the study aim will be crucial for patient recruitment. Another critical issue is the histopathological VAB evaluation of a non-tumorous specimen as this may have been taken either from the former tumor region (bpCR) or outside of the (former) tumor region (non-representative VAB, sampling error). Trial registration The trial has been registered at clinicaltrials.gov with the identifier NCT02948764 on October 28, 2016 and at the German Clinical Trials Register (DRKS00011761) on February 20, 2017. The date of enrolment of the first participant to the trial was on March 8, 2017. Keywords: Breast cancer, Neoadjuvant chemotherapy, Treatment response evaluation, Vacuum-assisted biopsy
Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery.BACKGROUNDNeoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery.This study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%.METHODSThis study is a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. The study will take place at 21 trial sites in Germany. Six hundred female patients with breast cancer after completed NACT showing at least a partial response to NACT treatment will be enrolled. A vacuum-assisted biopsy (VAB) guided either by ultrasound or mammography will be performed followed by histopathological evaluation of the VAB specimen before standard, guideline-adherent breast surgery. The study is designed to prove that the false negative rate of the VAB is below 10%.As a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery. During the study we anticipate possible problems in patient recruitment as the VAB intervention does not provide participating patients with any personal benefit. Hence, a proficient informed consent discussion with the patient and a detailed explanation of the study aim will be crucial for patient recruitment. Another critical issue is the histopathological VAB evaluation of a non-tumorous specimen as this may have been taken either from the former tumor region (bpCR) or outside of the (former) tumor region (non-representative VAB, sampling error).DISCUSSIONAs a bpCR is becoming a more frequent result after NACT, the question arises whether breast surgery is therapeutically necessary in such cases. To study this subject further, it will be crucial to develop a reliable test to diagnose a bpCR without surgery. During the study we anticipate possible problems in patient recruitment as the VAB intervention does not provide participating patients with any personal benefit. Hence, a proficient informed consent discussion with the patient and a detailed explanation of the study aim will be crucial for patient recruitment. Another critical issue is the histopathological VAB evaluation of a non-tumorous specimen as this may have been taken either from the former tumor region (bpCR) or outside of the (former) tumor region (non-representative VAB, sampling error).The trial has been registered at clinicaltrials.gov with the identifier NCT02948764 on October 28, 2016 and at the German Clinical Trials Register ( DRKS00011761 ) on February 20, 2017. The date of enrolment of the first participant to the trial was on March 8, 2017.TRIAL REGISTRATIONThe trial has been registered at clinicaltrials.gov with the identifier NCT02948764 on October 28, 2016 and at the German Clinical Trials Register ( DRKS00011761 ) on February 20, 2017. The date of enrolment of the first participant to the trial was on March 8, 2017.
ArticleNumber 851
Audience Academic
Author Riedel, Fabian
Thill, Marc
Reinisch, Mattea
Blohmer, Jens-Uwe
Kuemmel, Sherko
Thomas, Bettina
Karsten, Maria Margarete
Sinn, Peter
Heil, Joerg
Hennigs, André
Reimer, Toralf
Richter, Hannah
Golatta, Michael
Schaefgen, Benedikt
Hahn, Markus
Rauch, Geraldine
Hackmann, John
Pfob, André
Author_xml – sequence: 1
  givenname: Joerg
  surname: Heil
  fullname: Heil, Joerg
  email: Joerg.Heil@med.uni-heidelberg.de
  organization: Department of Gynecology, Breast Center, Heidelberg University
– sequence: 2
  givenname: Peter
  surname: Sinn
  fullname: Sinn, Peter
  organization: Department of Pathology, Heidelberg University
– sequence: 3
  givenname: Hannah
  surname: Richter
  fullname: Richter, Hannah
  organization: Department of Gynecology, Breast Center, Heidelberg University
– sequence: 4
  givenname: André
  surname: Pfob
  fullname: Pfob, André
  organization: Department of Gynecology, Breast Center, Heidelberg University
– sequence: 5
  givenname: Benedikt
  surname: Schaefgen
  fullname: Schaefgen, Benedikt
  organization: Department of Gynecology, Breast Center, Heidelberg University
– sequence: 6
  givenname: André
  surname: Hennigs
  fullname: Hennigs, André
  organization: Department of Gynecology, Breast Center, Heidelberg University
– sequence: 7
  givenname: Fabian
  surname: Riedel
  fullname: Riedel, Fabian
  organization: Department of Gynecology, Breast Center, Heidelberg University
– sequence: 8
  givenname: Bettina
  surname: Thomas
  fullname: Thomas, Bettina
  organization: Koordinierungszentrum für Klinische Studien (KKS), Heidelberg University
– sequence: 9
  givenname: Marc
  surname: Thill
  fullname: Thill, Marc
  organization: Department of Gynecology, Agaplesion Markus Hospital
– sequence: 10
  givenname: Markus
  surname: Hahn
  fullname: Hahn, Markus
  organization: Department of Gynecology, Tuebingen University
– sequence: 11
  givenname: Jens-Uwe
  surname: Blohmer
  fullname: Blohmer, Jens-Uwe
  organization: Department of Gynecology, Charité Universitaetsmedizin Berlin
– sequence: 12
  givenname: Sherko
  surname: Kuemmel
  fullname: Kuemmel, Sherko
  organization: Department of Gynecology, Hospital Kliniken Essen-Mitte
– sequence: 13
  givenname: Maria Margarete
  surname: Karsten
  fullname: Karsten, Maria Margarete
  organization: Department of Gynecology, Charité Universitaetsmedizin Berlin
– sequence: 14
  givenname: Mattea
  surname: Reinisch
  fullname: Reinisch, Mattea
  organization: Department of Gynecology, Hospital Kliniken Essen-Mitte
– sequence: 15
  givenname: John
  surname: Hackmann
  fullname: Hackmann, John
  organization: Department of Gynecology, Marien Hospital Witten
– sequence: 16
  givenname: Toralf
  surname: Reimer
  fullname: Reimer, Toralf
  organization: Department of Gynecology, Rostock University
– sequence: 17
  givenname: Geraldine
  surname: Rauch
  fullname: Rauch, Geraldine
  organization: Charité Universitaetsmedizin Berlin, Institute of Biometry and Clinical Epidemiology, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health Berlin, Berlin Institute of Health (BIH), Institute of Medical biometry and Informatics, Heidelberg University
– sequence: 18
  givenname: Michael
  surname: Golatta
  fullname: Golatta, Michael
  organization: Department of Gynecology, Breast Center, Heidelberg University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30144818$$D View this record in MEDLINE/PubMed
BookMark eNp9k81u1DAUhSNURH_gAdggS0gIpEmx82dng1SVApUqilpYWzeOM-ORY6e2M2J2vANvCC-Cw7S0UwHKwpH9nWPfY9_9ZMdYI5PkKcGHhLDqtScZY2WKCUsLWuG0eJDskYKSNCsw3bnzv5vse7_EmFCG2aNkN8ekKBhhe8nPi5PLT-cf355coB_fvqNWwdxYrzyyHRogLKy2cyVAI2H7QcsgkZN-sMZL1KzRCsQ49in4qAiyRY2yg18j6IJ0yEgL7XJcgQlILGRvw0I6GNZIGdQ4CT6gYzAikikC1I86KCFNVM7iZqZTroegVnKGYtEpuF62sygNDlJlWrVS7Qhar9PIBme1npbtIM3spohoh4JToB8nDzvQXj65Hg-SL-9OPh9_SM_O358eH52loqpYSIVkIi-hboDF3DAua8goo4TkJWZdRbOckpzmhZS4ZawTNKuauiq6pmy7PMcyP0hON76thSUfnOrBrbkFxX9PWDfn4OKptORNjpuiEV3XSSjqooQWclLloiSsLmidR683G69hbGLlUzAO9Jbp9opRCz63K14RXGesiAYvrw2cvRqlD7xXXkitId7L6HmG66IgNWbTXs_voUs7OhOj4ll0w7iihN1Sc4gFKNPZuK-YTPlRWRJKcYVxpA7_QsWvlb2KVyU7Fee3BK-2BNN1yq9hDqP3_PTyYpt9cYddSNBh4a0eg4oPcht8dje9P7HdvPsI0A0gnPXeyY4LFWDyicdVmhPMpw7jmw7jscP41GF8ypXcU96Y_0-TbTQ-smYu3W3A_xb9AldXOhY
CitedBy_id crossref_primary_10_1016_j_annonc_2019_10_012
crossref_primary_10_1245_s10434_023_14551_8
crossref_primary_10_1007_s00129_020_04590_7
crossref_primary_10_1016_j_ejso_2020_03_208
crossref_primary_10_1016_j_ejrad_2020_109025
crossref_primary_10_1245_s10434_019_07534_1
crossref_primary_10_24884_1607_4181_2024_31_2_28_43
crossref_primary_10_1590_0100_3984_2022_0078
crossref_primary_10_3390_s23041838
crossref_primary_10_1016_j_ejrad_2023_111270
crossref_primary_10_1007_s12609_024_00532_7
crossref_primary_10_3390_curroncol28050344
crossref_primary_10_3390_cancers14194545
crossref_primary_10_1007_s00330_024_10857_7
crossref_primary_10_3390_diagnostics13172811
crossref_primary_10_3390_cancers13102447
crossref_primary_10_1186_s13058_024_01883_w
crossref_primary_10_17116_onkolog20221106173
crossref_primary_10_1016_j_breast_2022_11_002
crossref_primary_10_1590_0100_3984_2022_0078_en
crossref_primary_10_1097_SLA_0000000000004246
crossref_primary_10_1111_tbj_13526
crossref_primary_10_1080_14740338_2019_1644318
crossref_primary_10_1007_s10549_020_05678_3
crossref_primary_10_1007_s12254_020_00632_x
crossref_primary_10_1016_j_crad_2020_03_024
crossref_primary_10_1245_s10434_021_10117_8
crossref_primary_10_1245_s10434_020_09273_0
crossref_primary_10_3390_cancers15051439
Cites_doi 10.1093/jncimonographs/lgr028
10.1245/s10434-015-4918-0
10.1002/cncr.22981
10.1016/S1470-2045(14)70160-3
10.1259/bjr/74430952
10.1016/S1470-2045(10)70207-2
10.1001/jama.2011.90
10.1038/modpathol.2015.74
10.1159/000127509
10.1200/JCO.2001.19.22.4224
10.1097/00000421-199306000-00006
10.1007/BF02968293
10.1245/s10434-011-2108-2
10.1200/JCO.2005.04.1665
10.1055/s-2007-1022338
10.1007/s10549-016-4016-4
10.1002/cncr.24874
10.1200/JCO.2005.02.6187
10.1245/s10434-017-5926-z
10.1200/JCO.1998.16.8.2672
10.1016/j.breast.2007.02.006
10.1093/oxfordjournals.jncimonographs.a003469
10.1055/s-0033-1347653
10.1093/jnci/dji021
10.1055/s-0032-1312831
10.1200/JCO.1999.17.2.460
10.1200/JCO.2011.38.8595
10.1016/j.humpath.2004.02.006
10.2174/1874375700903020058
10.1093/annonc/mdt182
10.1016/j.ejca.2016.09.034
ContentType Journal Article
Copyright The Author(s). 2018
COPYRIGHT 2018 BioMed Central Ltd.
Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s). 2018
– notice: COPYRIGHT 2018 BioMed Central Ltd.
– notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
ISR
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12885-018-4760-4
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



Publicly Available Content Database
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 7
ExternalDocumentID oai_doaj_org_article_b30b4bcfffea4945ada3163c51894793
PMC6109284
A551770600
30144818
10_1186_s12885_018_4760_4
Genre Journal Article
GeographicLocations United Kingdom--UK
Germany
GeographicLocations_xml – name: United Kingdom--UK
– name: Germany
GrantInformation_xml – fundername: Deutsche Forschungsgemeinschaft
  grantid: HE 6824/5-1; funding programme Open Access Publishing, by the Baden-Württemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universität Heidelberg
  funderid: http://dx.doi.org/10.13039/501100001659
– fundername: Deutsche Forschungsgemeinschaft
  grantid: funding programme Open Access Publishing, by the Baden-Württemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universität Heidelberg
– fundername: Deutsche Forschungsgemeinschaft
  grantid: HE 6824/5-1
– fundername: ;
  grantid: HE 6824/5-1; funding programme Open Access Publishing, by the Baden-Württemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universität Heidelberg
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
-A0
3V.
ACRMQ
ADINQ
C24
NPM
PMFND
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c668t-ce8c35a9ba84710059a2787113508f6723713734ee0d88fc726b964fb5df330e3
IEDL.DBID DOA
ISSN 1471-2407
IngestDate Wed Aug 27 01:29:44 EDT 2025
Thu Aug 21 13:31:35 EDT 2025
Fri Sep 05 08:55:36 EDT 2025
Fri Jul 25 02:48:08 EDT 2025
Tue Jun 17 21:41:34 EDT 2025
Tue Jun 10 20:41:31 EDT 2025
Fri Jun 27 03:35:41 EDT 2025
Thu May 22 20:43:13 EDT 2025
Wed Feb 19 02:42:04 EST 2025
Tue Jul 01 03:06:09 EDT 2025
Thu Apr 24 22:52:41 EDT 2025
Sat Sep 06 07:29:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Neoadjuvant chemotherapy
Vacuum-assisted biopsy
Breast cancer
Treatment response evaluation
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c668t-ce8c35a9ba84710059a2787113508f6723713734ee0d88fc726b964fb5df330e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://doaj.org/article/b30b4bcfffea4945ada3163c51894793
PMID 30144818
PQID 2109006718
PQPubID 44074
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_b30b4bcfffea4945ada3163c51894793
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6109284
proquest_miscellaneous_2094419083
proquest_journals_2109006718
gale_infotracmisc_A551770600
gale_infotracacademiconefile_A551770600
gale_incontextgauss_ISR_A551770600
gale_healthsolutions_A551770600
pubmed_primary_30144818
crossref_citationtrail_10_1186_s12885_018_4760_4
crossref_primary_10_1186_s12885_018_4760_4
springer_journals_10_1186_s12885_018_4760_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-08-25
PublicationDateYYYYMMDD 2018-08-25
PublicationDate_xml – month: 08
  year: 2018
  text: 2018-08-25
  day: 25
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC cancer
PublicationTitleAbbrev BMC Cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2018
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References HM Kuerer (4760_CR27) 2017; 24
B Fisher (4760_CR4) 1998; 16
E Provenzano (4760_CR31) 2015; 28
JA van der Hage (4760_CR10) 2001; 19
GF Schwartz (4760_CR16) 2004; 35
AE Giuliano (4760_CR29) 2011; 305
G von Minckwitz (4760_CR11) 2012; 30
M Hahn (4760_CR26) 2012; 33
4760_CR12
NS Goldstein (4760_CR8) 2007; 110
4760_CR5
A Hennigs (4760_CR2) 2016; 160
B Chevallier (4760_CR9) 1993; 16
B Schaefgen (4760_CR20) 2016; 23
HD Bear (4760_CR15) 2006; 24
D Mauri (4760_CR3) 2005; 97
HM Kuerer (4760_CR14) 1999; 17
A Schneeweiss (4760_CR19) 2013; 24
F Fan (4760_CR32) 2009; 3
J Heil (4760_CR25) 2016; 69
M Kaufmann (4760_CR22) 2010; 116
A Wockel (4760_CR23) 2008; 3
4760_CR21
M Kaufmann (4760_CR1) 2006; 24
A Rody (4760_CR7) 2007; 16
G von Minckwitz (4760_CR17) 2014; 15
HJ Shin (4760_CR18) 2011; 84
M Kurosumi (4760_CR13) 2004; 11
HP Sinn (4760_CR30) 1994; 54
M Kaufmann (4760_CR6) 2012; 19
H Preibsch (4760_CR24) 2013; 10
DN Krag (4760_CR28) 2010; 11
27744486 - Breast Cancer Res Treat. 2016 Dec;160(3):491-499
15687361 - J Natl Cancer Inst. 2005 Feb 2;97(3):188-94
22193884 - Ann Surg Oncol. 2012 May;19(5):1508-16
22723042 - Ultraschall Med. 2012 Aug;33(4):366-71
20087962 - Cancer. 2010 Mar 1;116(5):1184-91
20863759 - Lancet Oncol. 2010 Oct;11(10):927-33
21081579 - Br J Radiol. 2011 Jul;84(1003):612-20
26205180 - Mod Pathol. 2015 Sep;28(9):1185-201
21304082 - JAMA. 2011 Feb 9;305(6):569-75
8001751 - Geburtshilfe Frauenheilkd. 1994 Oct;54(10):552-8
8338056 - Am J Clin Oncol. 1993 Jun;16(3):223-8
16622270 - J Clin Oncol. 2006 Apr 20;24(12):1940-9
11709566 - J Clin Oncol. 2001 Nov 15;19(22):4224-37
9704717 - J Clin Oncol. 1998 Aug;16(8):2672-85
11773300 - J Natl Cancer Inst Monogr. 2001;(30):96-102
17722109 - Cancer. 2007 Oct 15;110(8):1687-96
22043061 - J Natl Cancer Inst Monogr. 2011;2011(43):138-41
22508812 - J Clin Oncol. 2012 May 20;30(15):1796-804
15550859 - Breast Cancer. 2004;11(2):139-47
15257539 - Hum Pathol. 2004 Jul;35(7):781-4
24794243 - Lancet Oncol. 2014 Jun;15(7):747-56
27821317 - Eur J Cancer. 2016 Dec;69:142-150
28766204 - Ann Surg Oncol. 2017 Oct;24(10):2855-2862
10080586 - J Clin Oncol. 1999 Feb;17(2):460-9
26467456 - Ann Surg Oncol. 2016 Mar;23(3):789-95
16606972 - J Clin Oncol. 2006 May 1;24(13):2019-27
21373209 - Breast Care (Basel). 2008;3(2):82-86
17449250 - Breast. 2007 Jun;16(3):235-40
23704196 - Ann Oncol. 2013 Sep;24(9):2278-84
References_xml – ident: 4760_CR5
  doi: 10.1093/jncimonographs/lgr028
– volume: 23
  start-page: 789
  issue: 3
  year: 2016
  ident: 4760_CR20
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-015-4918-0
– volume: 110
  start-page: 1687
  issue: 8
  year: 2007
  ident: 4760_CR8
  publication-title: Cancer
  doi: 10.1002/cncr.22981
– volume: 15
  start-page: 747
  issue: 7
  year: 2014
  ident: 4760_CR17
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(14)70160-3
– volume: 84
  start-page: 612
  issue: 1003
  year: 2011
  ident: 4760_CR18
  publication-title: Br J Radiol
  doi: 10.1259/bjr/74430952
– volume: 11
  start-page: 927
  issue: 10
  year: 2010
  ident: 4760_CR28
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(10)70207-2
– volume: 305
  start-page: 569
  issue: 6
  year: 2011
  ident: 4760_CR29
  publication-title: JAMA
  doi: 10.1001/jama.2011.90
– volume: 28
  start-page: 1185
  issue: 9
  year: 2015
  ident: 4760_CR31
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2015.74
– volume: 3
  start-page: 82
  issue: 2
  year: 2008
  ident: 4760_CR23
  publication-title: Breast Care (Basel)
  doi: 10.1159/000127509
– volume: 19
  start-page: 4224
  issue: 22
  year: 2001
  ident: 4760_CR10
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2001.19.22.4224
– volume: 16
  start-page: 223
  issue: 3
  year: 1993
  ident: 4760_CR9
  publication-title: Am J Clin Oncol
  doi: 10.1097/00000421-199306000-00006
– volume: 11
  start-page: 139
  issue: 2
  year: 2004
  ident: 4760_CR13
  publication-title: Breast Cancer
  doi: 10.1007/BF02968293
– volume: 19
  start-page: 1508
  issue: 5
  year: 2012
  ident: 4760_CR6
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-011-2108-2
– ident: 4760_CR21
– volume: 24
  start-page: 2019
  issue: 13
  year: 2006
  ident: 4760_CR15
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.04.1665
– volume: 54
  start-page: 552
  issue: 10
  year: 1994
  ident: 4760_CR30
  publication-title: Geburtshilfe Frauenheilkd
  doi: 10.1055/s-2007-1022338
– volume: 160
  start-page: 491
  issue: 3
  year: 2016
  ident: 4760_CR2
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-016-4016-4
– volume: 116
  start-page: 1184
  issue: 5
  year: 2010
  ident: 4760_CR22
  publication-title: Cancer
  doi: 10.1002/cncr.24874
– volume: 24
  start-page: 1940
  issue: 12
  year: 2006
  ident: 4760_CR1
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.02.6187
– volume: 24
  start-page: 2855
  issue: 10
  year: 2017
  ident: 4760_CR27
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-017-5926-z
– volume: 16
  start-page: 2672
  issue: 8
  year: 1998
  ident: 4760_CR4
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1998.16.8.2672
– volume: 16
  start-page: 235
  issue: 3
  year: 2007
  ident: 4760_CR7
  publication-title: Breast
  doi: 10.1016/j.breast.2007.02.006
– ident: 4760_CR12
  doi: 10.1093/oxfordjournals.jncimonographs.a003469
– volume: 10
  start-page: A118
  issue: 02
  year: 2013
  ident: 4760_CR24
  publication-title: Senologie - Zeitschrift für Mammadiagnostik und -therapie
  doi: 10.1055/s-0033-1347653
– volume: 97
  start-page: 188
  issue: 3
  year: 2005
  ident: 4760_CR3
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dji021
– volume: 33
  start-page: 366
  issue: 4
  year: 2012
  ident: 4760_CR26
  publication-title: Ultraschall Med
  doi: 10.1055/s-0032-1312831
– volume: 17
  start-page: 460
  issue: 2
  year: 1999
  ident: 4760_CR14
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1999.17.2.460
– volume: 30
  start-page: 1796
  issue: 15
  year: 2012
  ident: 4760_CR11
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.38.8595
– volume: 35
  start-page: 781
  issue: 7
  year: 2004
  ident: 4760_CR16
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2004.02.006
– volume: 3
  start-page: 58
  year: 2009
  ident: 4760_CR32
  publication-title: Open Pathol J
  doi: 10.2174/1874375700903020058
– volume: 24
  start-page: 2278
  issue: 9
  year: 2013
  ident: 4760_CR19
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdt182
– volume: 69
  start-page: 142
  year: 2016
  ident: 4760_CR25
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2016.09.034
– reference: 22043061 - J Natl Cancer Inst Monogr. 2011;2011(43):138-41
– reference: 26467456 - Ann Surg Oncol. 2016 Mar;23(3):789-95
– reference: 22723042 - Ultraschall Med. 2012 Aug;33(4):366-71
– reference: 9704717 - J Clin Oncol. 1998 Aug;16(8):2672-85
– reference: 11709566 - J Clin Oncol. 2001 Nov 15;19(22):4224-37
– reference: 11773300 - J Natl Cancer Inst Monogr. 2001;(30):96-102
– reference: 8001751 - Geburtshilfe Frauenheilkd. 1994 Oct;54(10):552-8
– reference: 27744486 - Breast Cancer Res Treat. 2016 Dec;160(3):491-499
– reference: 22193884 - Ann Surg Oncol. 2012 May;19(5):1508-16
– reference: 15257539 - Hum Pathol. 2004 Jul;35(7):781-4
– reference: 27821317 - Eur J Cancer. 2016 Dec;69:142-150
– reference: 28766204 - Ann Surg Oncol. 2017 Oct;24(10):2855-2862
– reference: 23704196 - Ann Oncol. 2013 Sep;24(9):2278-84
– reference: 26205180 - Mod Pathol. 2015 Sep;28(9):1185-201
– reference: 20087962 - Cancer. 2010 Mar 1;116(5):1184-91
– reference: 20863759 - Lancet Oncol. 2010 Oct;11(10):927-33
– reference: 15550859 - Breast Cancer. 2004;11(2):139-47
– reference: 17449250 - Breast. 2007 Jun;16(3):235-40
– reference: 16622270 - J Clin Oncol. 2006 Apr 20;24(12):1940-9
– reference: 21373209 - Breast Care (Basel). 2008;3(2):82-86
– reference: 22508812 - J Clin Oncol. 2012 May 20;30(15):1796-804
– reference: 15687361 - J Natl Cancer Inst. 2005 Feb 2;97(3):188-94
– reference: 10080586 - J Clin Oncol. 1999 Feb;17(2):460-9
– reference: 24794243 - Lancet Oncol. 2014 Jun;15(7):747-56
– reference: 16606972 - J Clin Oncol. 2006 May 1;24(13):2019-27
– reference: 17722109 - Cancer. 2007 Oct 15;110(8):1687-96
– reference: 21081579 - Br J Radiol. 2011 Jul;84(1003):612-20
– reference: 21304082 - JAMA. 2011 Feb 9;305(6):569-75
– reference: 8338056 - Am J Clin Oncol. 1993 Jun;16(3):223-8
SSID ssj0017808
Score 2.3954566
Snippet Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a...
Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological...
Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a...
Abstract Background Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 851
SubjectTerms Accuracy
Adjuvant chemotherapy
Biomedical and Life Sciences
Biomedicine
Biopsy
Breast cancer
Breast surgery
cancer imaging
Cancer Research
Cancer therapies
Care and treatment
Chemotherapy
Clinical trials
Diagnosis
Dissection
Health Promotion and Disease Prevention
interventional therapeutics
Mammography
Medicine/Public Health
Methods
Neoadjuvant chemotherapy
Oncology
Patient outcomes
Patients
Sampling error
Study Protocol
Surgery
Surgical Oncology
Treatment response evaluation
Ultrasonic imaging
Ultrasound
Vacuum
Vacuum-assisted biopsy
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELaglRAXxH8DBQxCQoK16iRO4pxQW7UqSC1VoVJvluM4ZdE2KZvdSnvjHXhDeBFmHG9Kiuh1Pc5m7PH4i_3NDCGvbchzrVPJeBEZJoxImK7ikFmAu2Wal9K4uLX9g3TvWHw8SU78gVvraZVLn-gcddkYPCPfiJBBCK41lO_PvzOsGoW3q76Exk2yCi5Ygp2vbu0cHB719wiZ5NLfZYYy3WhBSCJZDU-UUs7EYDdySfv_dc1_7U1XeZNXLk_dnrR7l9zxYJJudrN_j9yw9X1ya99flz8gv2F4Dz9hGAH99eMnLTta3bilTUWxFPHS8VFHLAf4TKcdZdbSYkEvtJnPzxigazSFkhbj5rxdUFdVnNa20eW3OeDwGYV5P_OBXAs6rmmBRPcZ3UaDmlJGNXW0RdTHTkfwZ3U1dkj5wo5oU1ump6DuCLqCvmzch4hNFswz6SfYjIW-Rksl4HHUVRx5SI53d75s7zFf1YGZNJUzZqw0caLzQuPGiMGvOgKvEYYxYMUqzaIYvpuzWFjLSykrk0VpkaeiKpKyimNu40dkpYZ3WyOUF2FY5VFUclGJErColrwsZZbDYwQA3YDw5ewq41OeY-WNiXKfPjJVnUEoMAiFBqFEQN72Xc67fB_XCW-hyfSCmKrb_dBMT5Vf-aqIeSEKU1WV1SIXiS51DCDYJKHM8VgzIC_Q4FQX99o7HLUJWDbD3EY8IK-cBKbrqJEPdKrnbas-fD4aCL3xQlUDOhrtwytgpDDD10ByfSAJ_sQMm5eWr7w_a9Xl6gvIy74ZeyJHD0xuDjI8B2ydA6YPyONuofQj4z7cJfbOBktoMHTDlnr81WU7x3oAgKEC8m652C5f678z8-R6JZ6S2xE6AQ67RLJOVmbTuX0G4HJWPPce5A9Tpnr6
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKkRAXxJtAAYOQkGANTuIkzgGhUlEVpAUEVOrNchy7LNpmS3ZTsTf-A_8Q_ggzTrIlpXDiuh5nY3se38TzIOSBDXmudSoZLyLDhBEJ0y4OmQW4W6Z5KY3PWxu_SXd2xeu9ZG-N9O2tug2cn-raYT-p3Xr65OuX5XMQ-Gde4GX6dA46VmIIGn4nSjkTZ8hZMEwp-mJjcXypkEkuu4vNU6cNTJOv4P-nnv7NUJ0Mojxxk-oN1PZFcqFDlnSzZYVLZM1Wl8m5cXd3foX8hL1-9xZzCuiPb99p2cbYTeZ05ij2Je61IPVR5oClad3Gz1paLOmRNk1zwABqI1-UtJjMDudL6luM08rOdPm5AVC-oMAEB11W15JOKlpg1PuCbiF31ZRRTX0MI67H1iP4s8pNPGw-siM6qyzTNSx3BFNhvWyyyhebLlkXVj_FYTylUb8IeBz17Ueukt3tlx-3dljX4oGZNJULZqw0caLzQqOVxExYHYEKCcMYgKNLsygGJzqLhbW8lNKZLEqLPBWuSEoXx9zG18h6Be92g1BehKHLo6jkwokSgKmWvCxllsNjBKDegPD-dJXp6p9jG46p8n6QTFXLEAoYQiFDKBGQR6sph23xj38Rv0CWWRFi3W7_w6zeV50aUEXMC1EY55zVIheJLnUMiNgkoczxG2dA7iLDqTYJdqV91CYA2wwLHfGA3PcUWLujwuCgfd3M5-rVh_cDoocdkZvBGo3uci1gp7Dc14ByY0AJysUMh3vOV71sqgiDeQHlhDIg91bDOBMD9oDlGqDhOQDtHAB-QK63grLaGe_FS5ydDURosHXDkWryyZc-x-YAAKgC8rgXtuPX-uvJ3PwfJ3OLnI9QVXAwLMkGWV_Ujb0NeHRR3PFa5hdsi4nu
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELagSIgL4p9AAYOQkGAtnMRxnGNZURWkAgIq9WY5jg1B22y1u6m0N96BN4QXYcbJhqb8SFzX42xsj8efM9_MEPLYxbwwRirGy8QyYUXGjE9j5gDuVrKolA1xa_tv5N6BeH2YHfbJojEW5rT_Plby-RLsp0J6GX4DkpyJ8-RCFqcy-GXldHAY5Iqr3mn5x26jYydk5__dBp86hM4SJM94ScPhs3uFXO5RI93plvkqOeeaa-Tifu8Xv05-wDy-e4vxAvT712-06vhz9ZLOPcWawxsLRwODHHAyXXTcWEfLNT0xtm2PGMBoXPOKlvX8eLmmoXw4bdzcVF9aANwrCgt81EdsrWnd0BIZ7Ss6Rc1ZUEYNDfxEHI9bTODPGl8HSHziJnTeOGYWMNwJdIXxsnqIBZutWU-Zn2EzVvSabAYBj6OhtMgNcrD78uN0j_XlG5iVUq2YdcqmmSlKgycgRrmaBMxDHKcACr3MkxQuyHkqnOOVUt7miSwLKXyZVT5NuUtvkq0G3u02obyMY18kScWFFxWATqN4Vam8gMcIQLQR4ZvV1bbPbY4lNmY63HGU1J1CaFAIjQqhRUSeDl2Ou8Qe_xJ-gSozCGJO7vADqKrut7guU16K0nrvnRGFyExlUkC7NotVgd8vI_IAFU53Aa6DZdE7AFpzTGLEI_IoSGBejgaJP59Mu1zqVx_ej4Se9EJ-DmO0po-jgJnCVF4jye2RJBgOO27eaL7uDddSJ0jUBQQTq4g8HJqxJ5LxQOVakOEFgOgCwHtEbnUbZZiZcENX2DsfbaHR1I1bmvpzSGuOif8BLEXk2Waz_Xqtv67Mnf-SvksuJWgTOJwO2TbZWi1adw9A5aq8H8zJT85fcjI
  priority: 102
  providerName: Springer Nature
Title RESPONDER – diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial
URI https://link.springer.com/article/10.1186/s12885-018-4760-4
https://www.ncbi.nlm.nih.gov/pubmed/30144818
https://www.proquest.com/docview/2109006718
https://www.proquest.com/docview/2094419083
https://pubmed.ncbi.nlm.nih.gov/PMC6109284
https://doaj.org/article/b30b4bcfffea4945ada3163c51894793
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZgkRAXxJvAUgxCQoJa6yRO4hzbalcL0i6rQqWKi-U4NhR101UfK_XGf-Afwh9hxknLZhFw4RKp9TjxYzL-HH8zQ8gLG_Jc61QyXkSGCSMSpl0cMgtwt0zzUhrvt3Z0nB6OxNtxMr6Q6gs5YXV44Hrg9oqYF6IwzjmrRS4SXeoYMIRJQpnjVyG0vjznm81Uc36QSS6bM8xQpnsLsMISSWr4JSnlTLRWIR-s_3eTfGFNusyXvHRo6teig1vkZgMiaa9u_G1yxVZ3yPWj5pj8LvkBw3ryDt0H6Pev32hZ0-kmCzpzFFMQbwwe9YRygM10XlNlLS3W9Fyb1eqUAapGFShpMZmdLdbUZxOnlZ3p8ssK8PeSwnyfNg5cazqpaIEE9yUdoCLNKaOaeroi9sfOu_Cwyk08Qj63XTqrLNNz6G4XqkJ_2WTrGjZds4ZBP8ViTPDV3XQCbkd9ppF7ZHSw_2FwyJpsDsykqVwyY6WJE50XGhdEdHrVEViLMIwBI7o0i2LYL2exsJaXUjqTRWmRp8IVSenimNv4PtmpoG0PCeVFGLo8ikounCgBg2rJy1JmOdxGAMANCN_MrjJNqHPMuDFVfssjU1UrhAKFUKgQSgTk1bbKWR3n42_CfVSZrSCG6PZ_gOKqRnHVvxQ3IE9R4VTt77o1NKoHGDbDmEY8IM-9BIbpqJAH9EmvFgv15v2wJfSyEXIz6KPRjVsFjBRG9mpJ7rYkwY6YdvFG81VjxxYqQt4uAJpQBuTZthhrIjcPVG4FMjwHTJ0Dlg_Ig_pF2Y6M37BLrJ21XqHW0LVLqslnH-Uc8wAAdgrI683L9qtZf5yZR_9jZh6TGxGaCg5rSLJLdpbzlX0C0HNZdMjVbJx1yLX-_vHJEH4N0kHHWx64HgkJ12H_I1xHUe8nDgeI0A
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtQwFLXKVAI2iDeBQg0CIcFYzcNJnAVCbWnV0gdVaaXujOM4ZVCblMlM0ez4B_6Dj4If4V4nmZIiuut2fO2J7evjY_s-CHluPDdRKhLMTX3NuOYhU3ngMQN0N4uSTGjrt7a1Ha3t8_cH4cEM-dn6wqBZZYuJFqizUuMd-YKPFoQArZ54e_KVYdYofF1tU2jUarFhJt_gyFa9WX8H8_vC91dX9pbXWJNVgOkoEiOmjdBBqJJUITCj86XyQWs9LwCukkexH8C5LQ64MW4mRK5jP0qTiOdpmOVw-DcBtHuFzHL0aO2R2aWV7Z3d6btFLFzRvJ16IlqoAP0FGsfhDVbkMt7Z_WySgH-3gr_2wvN2mucea-0euHqT3GjIK12ste0WmTHFbXJ1q3mev0N-w3TufEC3Bfrr-w-a1WZ8g4qWOcXUxy3QUmvIDnSdDmsTXUPTCT1Vejw-ZsDmUfUymg7Kk2pCbRZzWphSZV_GwPtHFPTsuHEcm9BBQVM0rB_RZVTgIWVUUWsmif0xwz78WZEPLDM_NX1aFoapIXS3D1Whv2wwdUk7mrDGcv8IizGxWL_tBDRHbYaTu2T_Uub7HukV8G0PCHVTz8sT389cnvMMuK8SbpaJOIFmOBBrh7jt7ErdhFjHTB9H0h61RCRrhZCgEBIVQnKHvJpWOanji1wkvIQqMxXE0OD2h3J4KBukkWngpjzVeZ4bxRMeqkwFQLp16IkEr1EdMo8KJ2s_2ynAyUXgzjHGUnId8sxKYHiQAu2PDtW4quT6x92O0MtGKC-hj1o17hwwUhhRrCM515EE_NLd4lbzZYOflTxb7Q55Oi3GmmgTCCo3Bhk3AS6fwBnCIffrhTIdGXtRILB23FlCnaHrlhSDzza6OuYfAM7mkNftYjv7rP_OzMOLOzFPrq3tbW3KzfXtjUfkuo-A4MIOFc6R3mg4No-B2I7SJw2aUPLpsgHsD2Xutfk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bbtQwELWgSBUviHsDhRqEhARr1UmcxHkshaoFWiqgUt8sx7HLom222uxW2jf-gT-EH2HGuUDKReJ1Pc7G9nh8nDkzQ8gTG_Jc61QyXkSGCSMSpl0cMgtwt0zzUhoft7Z_kO4eidfHyXFb57Tu2O6dS7KJacAsTdV886x0zRaX6WYNVlUi6Qy_DKWcicvkisCTD7216XbvRsgkl60r84_dBoeRz9n_u2X-5Wi6SJu84Dv1R9LOdXKtxZJ0q1n8G-SSrW6S1f3WW36LfIfZPXyHUQT025evtGxYdeOaTh3FSsSd3aOeVw7omc4axqylxZKea7NYnDIA16gJJS3G07N6SX1RcVrZqS4_LwCGzyks-2kbx7Wk44oWyHOf023UpxllVFPPWsTx2NkI_qxyYw-Uz-2ITivL9AyGO4KuMF427iPEJkvWEukn2Ix1vkbdIOBx1BccuU2Odl593N5lbVEHZtJUzpmx0sSJzguN5yLGvuoIjEYYxgAVXZpFMVybs1hYy0spncmitMhT4YqkdHHMbXyHrFTwbmuE8iIMXR5FJRdOlABFteRlKbMcHiMA5waEd6urTJvxHAtvTJS_-chUNQqhQCEUKoQSAXnWdzlr0n38S_gFqkwviJm6_Q_T2YlqN74qYl6IwjjnrBa5SHSpY8DAJglljl81A7KBCqeasNfe3qgtgLIZpjbiAXnsJTBbR4V0oBO9qGu19-H9QOhpK-SmMEaj2-gKmClM8DWQXB9Igjkxw-ZO81VrzmoVIX0XcE0oA_Kob8aeSNEDlVuADM8BWucA6QNyt9ko_cz4e7vE3tlgCw2mbthSjT_5ZOdYDgAgVECed5vt52v9dWXu_Zf0Blk9fLmj3u4dvLlPrkZoHjgcH8k6WZnPFvYBoM558dBblh_D231m
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=RESPONDER+%E2%80%93+diagnosis+of+pathological+complete+response+by+vacuum-assisted+biopsy+after+neoadjuvant+chemotherapy+in+breast+Cancer+-+a+multicenter%2C+confirmative%2C+one-armed%2C+intra-individually-controlled%2C+open%2C+diagnostic+trial&rft.jtitle=BMC+cancer&rft.au=Joerg+Heil&rft.au=Peter+Sinn&rft.au=Hannah+Richter&rft.au=Andr%C3%A9+Pfob&rft.date=2018-08-25&rft.pub=BMC&rft.eissn=1471-2407&rft.volume=18&rft.issue=1&rft.spage=1&rft.epage=7&rft_id=info:doi/10.1186%2Fs12885-018-4760-4&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b30b4bcfffea4945ada3163c51894793
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon